In Q1'27, R&D Expenses reached 408M USD while SG&A Expenses stood at 666M USD, representing the latest data points in the operating expenses breakdown. From Q2'24 to Q1'27, both R&D and SG&A expenses demonstrated consistent upward trends with R&D growing from 179M USD to 408M USD and SG&A expanding from 385M USD to 666M USD, though SG&A expenses showed a notable decline in Q4'26 before rebounding in Q1'27, while R&D maintained steady quarterly increases throughout the period.